GLP-1 medications are FDA approved for type 2 diabetes and obesity, but questions remain about whether they suit every age group.
Recap by typeshit. Full story at Medical Xpress.
NewsNation reports doctors' guidance on pausing GLP-1 medications ahead of pregnancy. The full story has their reasoning.
The piece examines claims that taking smaller GLP-1 doses brings weight loss with fewer side effects, and asks how well that holds up.
10 News reports Australians are ending up in hospital after using unregulated peptides, prompting warnings from two state health departments.
A former peptide chemist covered the AAPM conference as the FDA weighs letting pharmacies compound BPC-157 and others, and found sizable gaps in the evidence advocates cite.
IE Lifestyle reports on new research tying GLP-1 use to nail and hair problems, with two experts weighing in on the findings.
Femail's Olivia Falcon describes the steps she took after rapid weight loss on a fat jab changed her face, and says others can follow them.
Loading…